Cargando…
Surrogate Biomarkers for Monitoring Healthcare Quality for Chronic Diseases Such as Diabetes Care
Some laboratory tests or biomarkers are used as surrogate outcomes for health care effectiveness. HbA1c is defined as a surrogate biomarker since HbA1c values have been approved to be used in predictions of clinically important complications of diabetes mellitus. With the advance of information tech...
Autor principal: | Aslan, Diler |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295596/ https://www.ncbi.nlm.nih.gov/pubmed/30574042 |
Ejemplares similares
-
Which Skills are Needed and How They Should be Gained by Laboratory Medicine Professionals for Successful ISO 15189 Accreditation
por: Aslan, Diler
Publicado: (2018) -
Assessment of estimated glomerular filtration rate based on cystatin
C in diabetic nephropathy
por: Akpınar, Kadriye, et al.
Publicado: (2021) -
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML
por: Meddi, Elisa, et al.
Publicado: (2023) -
Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes
por: Sibal, Latika, et al.
Publicado: (2011) -
Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine
por: Wang, Liang
Publicado: (2010)